Literature DB >> 13492175

Pharmacological properties of hydrallazine, dihydrallazine and some related compounds.

S M KIRPEKAR, J J LEWIS.   

Abstract

Entities:  

Keywords:  HYDRALAZINE

Mesh：

Substances：

Year:  1957        PMID： 13492175     DOI： 10.1111/j.2042-7158.1957.tb12349.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  4 in total

1.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

2.  Increased levels of prostaglandin-like material in the canine blood during arterial hypotension produced by hydralazine, dihydralazine and minoxidil.

Authors:  G Haeusler; M Gerold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

3.  Some effects of reserpine and hydraliazine upon tissue respiration and the concentration of adenosine nucleotides in certain tissues.

Authors:  S M KIRPEKAR; J J LEWIS
Journal:  Br J Pharmacol Chemother       Date:  1959-03

4.  Inhibition of calcium release from the sarcoplasmic reticulum of rabbit aorta by hydralazine.

Authors:  A M Gurney; M Allam
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.